UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Different Silver Nanoparticles in One Crystal: Ag210(iPrPhS)71(Ph3P)5Cl and Ag211(iPrPhS)71(Ph3P)6Cl

Angewandte Chemie International Edition, 2019-01, Vol.58 (1), p.195-199

International ed. in English, 2019

Volltextzugriff (PDF)

Do R&D investments in weak IPR countries destroy market value? The role of internal linkages

Strategic management journal, 2021-08, Vol.42 (8), p.1401-1431

2021

Volltextzugriff (PDF)

Projections of ipRGCs and conventional RGCs to retinorecipient brain nuclei

Journal of comparative neurology (1911), 2021-06, Vol.529 (8), p.1863-1875

2021

Volltextzugriff (PDF)

Polyhydrido Copper Nanoclusters with a Hollow Icosahedral Core: [Cu30H18{E2P(OR)2}12] (E=S or Se; R=nPr, iPr or iBu)

Chemistry : a European journal, 2020-08, Vol.26 (46), p.10471-10479

2020

Volltextzugriff (PDF)

Divergent projection patterns of M1 ipRGC subtypes

Journal of comparative neurology (1911), 2018-09, Vol.526 (13), p.2010-2018

2018

Volltextzugriff (PDF)

The response of soil and phyllosphere microbial communities to repeated application of the fungicide iprodione: accelerated biodegradation or toxicity?

FEMS microbiology ecology, 2020-06, Vol.96 (6), p.1

2020

Volltextzugriff (PDF)

[Pd(IPr)(cinnamyl)Cl]: An Efficient Pre-catalyst for the Preparation of Tetra-ortho-substituted Biaryls by Suzuki-Miyaura Cross-Coupling

Chemistry : a European journal, 2012-04, Vol.18 (15), p.4517-4521

2012

Volltextzugriff (PDF)

Using Ipratropium Bromide Nasal Spray Response as a Screening Tool in the Diagnostic Workup of Cerebrospinal Fluid Rhinorrhea

The Laryngoscope, 2024-01, Vol.134 (1), p.56-61

2024

Volltextzugriff (PDF)

The Dialuminene AriPr8AlAlAriPr8 (AriPr8 = C6H‐2,6‐(C6H2‐2,4,6‐iPr3)2‐3,5‐iPr2)

Angewandte Chemie International Edition, 2024-08, p.e202412599

2024

Volltextzugriff (PDF)

IPrF - Highly Hindered, Fluorinated N-Heterocyclic Carbenes

Chemistry : a European journal, 2024-09, p.e202402847

2024

Volltextzugriff (PDF)

Ipratropium Bromide Nasal Spray in Non-Allergic Rhinitis: A Systematic Review and Meta-Analysis

The Laryngoscope, 2023-12, Vol.133 (12), p.3247-3255

2023

Volltextzugriff (PDF)

Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study

Diabetes, obesity & metabolism, 2015-03, Vol.17 (3), p.304-308

2015

Volltextzugriff (PDF)

Wingtip‐Flexible N‐Heterocyclic Carbenes: Unsymmetrical Connection between IMes and IPr

Angewandte Chemie International Edition, 2024-02, Vol.63 (8), p.e202318703-n/a

International ed. in English, 2024

Volltextzugriff (PDF)

Erythropoiesis and estimated fluid volume regulation following initiation of ipragliflozin treatment in patients with type 2 diabetes mellitus and chronic kidney disease: A post‐hoc analysis of the PROCEED trial

Diabetes, obesity & metabolism, 2024-05, Vol.26 (5), p.1723-1730

2024

Volltextzugriff (PDF)

Glucagon secretion and its association with glycaemic control and ketogenesis during sodium‐glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open‐label, prospective study

Diabetes, obesity & metabolism, 2024-05, Vol.26 (5), p.1605-1614

2024

Volltextzugriff (PDF)

Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats

Journal of pharmacy and pharmacology, 2014-07, Vol.66 (7), p.975-987

2014

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long-Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment (LANTERN) study

Diabetes, obesity & metabolism, 2015-02, Vol.17 (2), p.152-160

2015

Volltextzugriff (PDF)

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD

Hepatology communications, 2022-01, Vol.6 (1), p.120-132

2022

Volltextzugriff (PDF)

Vascular and metabolic effects of ipragliflozin versus sitagliptin (IVS) in type 2 diabetes treated with sulphonylurea and metformin: IVS study

Diabetes, obesity & metabolism, 2023-07, Vol.25 (7), p.1922-1931

2023

Volltextzugriff (PDF)

Ipriflavone as a non‐steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice

Aging cell, 2022-03, Vol.21 (3), p.e13572-n/a

2022

Volltextzugriff (PDF)

Ipriflavone suppresses NLRP3 inflammasome activation in host response to biomaterials and promotes early bone healing

Journal of clinical periodontology, 2022-08, Vol.49 (8), p.814-827

2022

Volltextzugriff (PDF)

Comparative study of the effects of ipragliflozin and sitagliptin on multiple metabolic variables in Japanese patients with type 2 diabetes: A multicentre, randomized, prospective, open‐label, active‐controlled study

Diabetes, obesity & metabolism, 2018-11, Vol.20 (11), p.2675-2679

2018

Volltextzugriff (PDF)

Small molecules (CO2, iPrNCO, and iPrNCNiPr) activation by the metallomimetics (μ‐Hydrido) diborane anion: A DFT investigation on mechanism and chemoselectivity controlling

Journal of computational chemistry, 2024-03, Vol.45 (6), p.331-340

2024

Volltextzugriff (PDF)

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)

Diabetes, obesity & metabolism, 2019-08, Vol.21 (8), p.1990-1995

2019

Volltextzugriff (PDF)

Metabolomic analysis of serum samples from a clinical study on ipragliflozin and metformin treatment in Japanese patients with type 2 diabetes: Exploring human metabolites associated with visceral fat reduction

Pharmacotherapy, 2023-12, Vol.43 (12), p.1317-1326

2023

Volltextzugriff (PDF)

1 – 25 von 29.462

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27.073)
Mit Volltextzugriff
(27.330)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(20.151)
Life Sciences & Biomedicine
(9.967)
Physical Sciences
(7.020)
Chemistry
(6.561)
Humans
(4.837)
Technology
(4.548)
Engineering
(3.703)
Engineering, Electrical & Electronic
(3.385)
Computer Science
(3.323)
Chemistry, Multidisciplinary
(3.302)
Computer Science, Artificial Intelligence
(3.158)
Imaging Science & Photographic Technology
(3.126)
Male
(2.758)
Female
(2.470)
Animals
(2.333)
Biological And Medical Sciences
(2.201)
Pharmacology & Pharmacy
(1.818)
Social Sciences
(1.769)
Catalysis
(1.635)
Medical Sciences
(1.386)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley Blackwell Single Titles
(29.462)
EZB Electronic Journals Library
(8.868)
MEDLINE
(8.383)
Journals@Ovid Full Text
(8.381)
IEEE Xplore
(3.438)
Ingenta
(2.600)
IngentaConnect Journals
(2.238)
Single Journals
(1.704)
BSC - Ebsco (Business Source Ultimate)
(1.438)
JSTOR
(1.141)
Oxford Journals
(682)
PAIS Index
(541)
Psychology & Behavioral Sciences Collection (EBSCO)
(517)
Taylor & Francis Journals Auto-Holdings Collection
(338)
SpringerLink
(333)
Applied Social Sciences Index & Abstracts (ASSIA)
(308)
Worldwide Political Science Abstracts
(274)
Taylor & Francis
(273)
Elsevier ScienceDirect Journals
(268)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Iet Image Processing
(3.209)
Angewandte Chemie
(2.355)
Chemistry : A European Journal
(1.447)
Cheminform
(1.348)
Angewandte Chemie International Edition
(1.347)
European Journal Of Inorganic Chemistry
(751)
Chemistry – A European Journal
(395)
European Journal Of Organic Chemistry
(377)
Chemistry
(353)
Advanced Synthesis & Catalysis
(334)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Different Silver Nanoparticles in One Crystal: Ag210(iPrPhS)71(Ph3P)5Cl and Ag211(iPrPhS)71(Ph3P)6Cl

Do R&D investments in weak IPR countries destroy market value? The role of internal linkages

Projections of ipRGCs and conventional RGCs to retinorecipient brain nuclei

Polyhydrido Copper Nanoclusters with a Hollow Icosahedral Core: [Cu30H18{E2P(OR)2}12] (E=S or Se; R=nPr, iPr or iBu)

Divergent projection patterns of M1 ipRGC subtypes

The response of soil and phyllosphere microbial communities to repeated application of the fungicide iprodione: accelerated biodegradation or toxicity?

[Pd(IPr)(cinnamyl)Cl]: An Efficient Pre-catalyst for the Preparation of Tetra-ortho-substituted Biaryls by Suzuki-Miyaura Cross-Coupling

Using Ipratropium Bromide Nasal Spray Response as a Screening Tool in the Diagnostic Workup of Cerebrospinal Fluid Rhinorrhea

The Dialuminene AriPr8AlAlAriPr8 (AriPr8 = C6H‐2,6‐(C6H2‐2,4,6‐iPr3)2‐3,5‐iPr2)

IPrF - Highly Hindered, Fluorinated N-Heterocyclic Carbenes

Ipratropium Bromide Nasal Spray in Non-Allergic Rhinitis: A Systematic Review and Meta-Analysis

Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study

Wingtip‐Flexible N‐Heterocyclic Carbenes: Unsymmetrical Connection between IMes and IPr

Erythropoiesis and estimated fluid volume regulation following initiation of ipragliflozin treatment in patients with type 2 diabetes mellitus and chronic kidney disease: A post‐hoc analysis of the PROCEED trial

Glucagon secretion and its association with glycaemic control and ketogenesis during sodium‐glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open‐label, prospective study

Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats

A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long-Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment (LANTERN) study

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD

Vascular and metabolic effects of ipragliflozin versus sitagliptin (IVS) in type 2 diabetes treated with sulphonylurea and metformin: IVS study

Ipriflavone as a non‐steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice

Ipriflavone suppresses NLRP3 inflammasome activation in host response to biomaterials and promotes early bone healing

Comparative study of the effects of ipragliflozin and sitagliptin on multiple metabolic variables in Japanese patients with type 2 diabetes: A multicentre, randomized, prospective, open‐label, active‐controlled study

Small molecules (CO2, iPrNCO, and iPrNCNiPr) activation by the metallomimetics (μ‐Hydrido) diborane anion: A DFT investigation on mechanism and chemoselectivity controlling

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)

Metabolomic analysis of serum samples from a clinical study on ipragliflozin and metformin treatment in Japanese patients with type 2 diabetes: Exploring human metabolites associated with visceral fat reduction

Aktive Filter

Suchergebnisse filtern